Al Hammadi Company For Development and Investment
Saudi Stock Exchange 4007.SR
Al Hammadi Company For Development and Investment Price to Book Ratio (P/B) on January 14, 2025: 3.63
-
Al Hammadi Company For Development and Investment 52-week high Price to Book Ratio (P/B) is 5.93 on February 07, 2024, which is 63.20% above the current Price to Book Ratio (P/B).
-
Al Hammadi Company For Development and Investment 52-week low Price to Book Ratio (P/B) is 3.31 on December 25, 2024, which is -9.00% below the current Price to Book Ratio (P/B).
-
Al Hammadi Company For Development and Investment average Price to Book Ratio (P/B) for the last 52 weeks is 4.18.
| Date | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield | Price to Earnings Ratio (P/E) |
|---|
| CEO | Mr. Mohammad Bin Saleh Bin Mohammad Al Hammadi |
| IPO Date | July 15, 2014 |
| Location | Saudi Arabia |
| Headquarters | PO Box 55004 |
| Employees | 3,245 |
| Sector | Health Care |
| Industries | |
Al Hammadi Company For Development and Investment establishes, maintains, manages, and operates hospitals and medical centers in the Kingdom of Saudi Arabia. The company operates through Medical Services and Pharmaceuticals Products segments. It is also involved in the wholesale and retail trading of medical equipment, pharmaceutical and cosmetic products, and food and beverages; and the acquisition and rental of land for constructing buildings. In addition, the company invests in various industrial projects; and establishes, operates, and maintains commercial centers. It operates three hospitals under the Al Hammadi Hospital name in Olaya, Suwaidi, and Al Nuzha districts of Riyadh. The company was founded in 1985 and is based in Riyadh, the Kingdom of Saudi Arabia.
Past 5 years
USD 23.52
USD 41.76
USD 79.48
USD 25.46
StockViz Staff
January 15, 2025
Any question? Send us an email